Evidence map›Paper›PMID 33311801›Full record

ArticleNagoya journal of medical science2020

Assessment of the association between the polymorphism rs1256031 of the estrogen receptor β gene and GDM susceptibility.

Xi Li, Jindi Su, Kaifeng Zheng, Sheng Lin, Shiguo Chen, Baojiang Wang, Liping Lai, Shan Duan

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nagoya journal of medical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Nuclear Receptors in Pregnancy and Outcomes: Clinical Perspective.Advances in experimental medicine and biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xi LiLaboratory of Medical Genetics, Shenzhen Health Development Research Center, Shenzhen, China.
Jindi SuLaboratory of Medical Genetics, Shenzhen Health Development Research Center, Shenzhen, China.
Kaifeng ZhengLaboratory of Medical Genetics, Shenzhen Health Development Research Center, Shenzhen, China.
Sheng LinLaboratory of Medical Genetics, Shenzhen Health Development Research Center, Shenzhen, China.
Shiguo ChenLaboratory of Medical Genetics, Shenzhen Health Development Research Center, Shenzhen, China.
Baojiang WangLaboratory of Medical Genetics, Shenzhen Health Development Research Center, Shenzhen, China.
Liping LaiEndocrine Department, Futian Center for Chronic Disease Control, Shenzhen, China.
Shan DuanLaboratory of Medical Genetics, Shenzhen Health Development Research Center, Shenzhen, China.
Development Research Center · CNShenzhen Chronic Disease Prevention Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Estrogen has an important role in regulating glucose homeostasis, and existing evidence indicates that it might be involved in the development of hyperglycemia in pregnancy. It mediates its effect through estrogen receptors including the nuclear receptor ERβ encoded by

Indexed as

Diabetes, GestationalAdultAsian PeopleChinaEstrogen Receptor betaEstrogensFemaleGenetic Predisposition to DiseaseHumansHyperglycemiaPolymorphism, Single NucleotidePregnancyESR2 protein, humanEstrogen Receptor betaEstrogensestrogen receptor βgestational diabetes mellitussingle nucleotide polymorphism

Identifiers

PMID33311801
PMCPMC7719448
OpenAlexW3115700872

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.